Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2019, Article ID 2647068, 15 pages
https://doi.org/10.1155/2019/2647068
Research Article

NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs

1Cancer Research and Translational Medicine Research Unit, University of Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
2Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
3Infrastructure for Population Studies, Faculty of Medicine, University of Oulu, Oulu, Finland
4Department of Pathology, Lapland Central Hospital, Rovaniemi, Finland
5Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, Oulu, Finland

Correspondence should be addressed to Peeter Karihtala; if.uluo@alathirak.reteep

Received 10 March 2019; Revised 7 June 2019; Accepted 25 June 2019; Published 4 September 2019

Guest Editor: Kanhaiya Singh

Copyright © 2019 Mari Hämäläinen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. de la Vega, E. Chapman, and D. D. Zhang, “NRF2 and the Hallmarks of Cancer,” Cancer Cell, vol. 34, no. 1, pp. 21–43, 2018. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Geismann, A. Arlt, S. Sebens, and H. Schafer, “Cytoprotection “gone astray”: Nrf2 and its role in cancer,” OncoTargets and Therapy, vol. 2014, no. 7, pp. 1497–1518, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. M. DeNicola, F. A. Karreth, T. J. Humpton et al., “Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis,” Nature, vol. 475, no. 7354, pp. 106–109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Tian, M. R. de la Vega, C. J. Schmidlin, A. Ooi, and D. D. Zhang, “Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2),” Journal of Biological Chemistry, vol. 293, no. 6, pp. 2029–2040, 2018. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Wang and J. Y. Chan, “Nrf1 Is Targeted to the Endoplasmic Reticulum Membrane by an N-terminal Transmembrane Domain,” Journal of Biological Chemistry, vol. 281, no. 28, pp. 19676–19687, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Fattore, S. Costantini, D. Malpicci et al., “MicroRNAs in melanoma development and resistance to target therapy,” Oncotarget, vol. 8, no. 13, pp. 22262–22278, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Cheng, C.-H. Ku, and R. C. M. Siow, “Regulation of the Nrf2 antioxidant pathway by microRNAs: new players in micromanaging redox homeostasis,” Free Radical Biology & Medicine, vol. 64, pp. 4–11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. P. E. Bennett, L. Bemis, D. A. Norris, and Y. G. Shellman, “miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma,” Physiological Genomics, vol. 45, no. 22, pp. 1049–1059, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. C. L. Ross, S. Kaushik, R. Valdes-Rodriguez, and R. Anvekar, “MicroRNAs in cutaneous melanoma: role as diagnostic and prognostic biomarkers,” Journal of Cellular Physiology, vol. 233, no. 7, pp. 5133–5141, 2018. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Y. Li, L. L. Zheng, T. T. Wang, and M. Hu, “Functional Annotation of Metastasis-associated MicroRNAs of Melanoma,” Chinese Medical Journal, vol. 129, no. 20, pp. 2484–2490, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Mohammadpour, M. Derakhshan, H. Darabi, P. Hedayat, and M. Momeni, “Melanoma: Where we are and where we go,” Journal of Cellular Physiology, vol. 234, no. 4, pp. 3307–3320, 2018. View at Publisher · View at Google Scholar · View at Scopus
  12. H. R. Hintsala, E. Jokinen, K. M. Haapasaari et al., “Nrf2/Keap1 Pathway and Expression of Oxidative Stress Lesions 8-hydroxy-2’-deoxyguanosine and Nitrotyrosine in Melanoma,” Anticancer Research, vol. 36, no. 4, pp. 1497–1506, 2016. View at Google Scholar
  13. H. R. Hintsala, K. M. Haapasaari, Y. Soini, and P. Karihtala, “An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2'-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma,” Histology and Histopathology, vol. 32, no. 2, pp. 129–136, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. H.-C. Huang, T. Nguyen, and C. B. Pickett, “Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription,” Journal of Biological Chemistry, vol. 277, no. 45, pp. 42769–42774, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Xu, S. S. Shen, Y. Hoshida et al., “Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases,” Molecular Cancer Research, vol. 6, no. 5, pp. 760–769, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Kabbarah, C. Nogueira, B. Feng et al., “Integrative genome comparison of primary and metastatic melanomas,” PLoS ONE, vol. 5, no. 5, p. e10770, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Mitsui, F. Kiecker, A. Shemer et al., “Discrimination of dysplastic nevi from common melanocytic nevi by cellular and molecular criteria,” Journal of Investigative Dermatology, vol. 136, no. 10, pp. 2030–2040, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Kallio, J. T. Tuimala, T. Hupponen et al., “Chipster: user-friendly analysis software for microarray and other high-throughput data,” BMC Genomics, vol. 12, no. 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. American Joint Committee on Cancer, “Melanoma of the skin,” in AJCC Cancer Staging Manual, M. B. Amin, S. Edge, F. Greene, D. R. Byrd, and R. K. Brookland, Eds., Springer, New York, NY, 8th ed edition, 2016. View at Google Scholar
  21. H. Digaleh, M. Kiaei, and F. Khodagholi, “Nrf2 and Nrf1 signaling and ER stress crosstalk: implication for proteasomal degradation and autophagy,” Cellular and Molecular Life Sciences, vol. 70, no. 24, pp. 4681–4694, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. Nikitina, E. I. Sharova, S. A. Danilenko et al., “Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients,” Oncotarget, vol. 8, no. 20, pp. 32990–33001, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhao, L. Min, C. Xu et al., “Construction of disease-specific transcriptional regulatory networks identifies co-activation of four gene in esophageal squamous cell carcinoma,” Oncology Reports, vol. 38, no. 1, pp. 411–417, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Hersey and X. D. Zhang, “Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanoma,” Pigment Cell & Melanoma Research, vol. 21, no. 3, pp. 358–367, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. D. H. Oh, D. Rigas, A. Cho, and J. Y. Chan, “Deficiency in the nuclear-related factor erythroid 2 transcription factor (Nrf1) leads to genetic instability,” The FEBS Journal, vol. 279, no. 22, pp. 4121–4130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Han, M. Ming, R. Zhao, J. Pi, C. Wu, and Y.-Y. He, “Nrf1 CNC-bZIP protein promotes cell survival and nucleotide excision repair through maintaining glutathione homeostasis,” Journal of Biological Chemistry, vol. 287, no. 22, pp. 18788–18795, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Kari, H.-R. Teppo, K.-M. Haapasaari et al., “Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP,” Journal of Clinical Pathology, vol. 72, no. 4, pp. 316–321, 2019. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Wang, C. Zhang, L. Qin et al., “The prognostic value of NRF2 in solid tumor patients: a meta-analysis,” Oncotarget, vol. 9, no. 1, pp. 1257–1265, 2018. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Wolf, G. Goebel, H. Hackl, and H. Fiegl, “Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients,” BMC Cancer, vol. 16, no. 1, p. 821, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Lau, W. Tian, S. A. Whitman, and D. D. Zhang, “The predicted molecular weight of Nrf2: it is what it is not,” Antioxid Redox Signal, vol. 18, no. 1, pp. 91–93, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Li, J. Lyu, and Q. H. Meng, “MiR-93 Promotes Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer Cells by Activating the PI3K/Akt Pathway via Inhibition ofLKB1/PTEN/CDKN1A,” Journal of Cancer, vol. 8, no. 5, pp. 870–879, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Gao, K. Deng, X. Liu et al., “Molecular mechanism and role of microRNA-93 in human cancers: a study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation,” Journal of Cellular Biochemistry, vol. 120, no. 4, pp. 6370–6383, 2019. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Goswami, R. S. Tarapore, A. M. Poenitzsch Strong et al., “MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor (MITF) mRNA is inhibited by coding region determinant-binding protein (CRD-BP),” J Biol Chem, vol. 290, no. 1, pp. 384–395, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. A. M. Poenitzsch Strong, V. Setaluri, and V. S. Spiegelman, “MicroRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma,” Archives of Biochemistry and Biophysics, vol. 563, pp. 118–124, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. Q. J. Guo, J. N. Mills, S. G. Bandurraga et al., “MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer,” Breast Cancer Research, vol. 15, no. 4, p. R70, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Chen, Y. Li, Z. Yu et al., “Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma,” Molecular Medicine Reports, vol. 12, no. 2, pp. 3061–3066, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Yu, X. Zhang, T. Bi et al., “MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma,” Tumour Biology, vol. 34, no. 6, pp. 3501–3508, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Zhang, G. Guo, G. Wang et al., “Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma,” Molecular Medicine Reports, vol. 12, no. 6, pp. 8021–8031, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Chen, Z. Tang, Y. Sun et al., “miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes,” Experimental and Therapeutic Medicine, vol. 3, no. 2, pp. 351–356, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. C. E. Vejnar, M. Blum, and E. M. Zdobnov, “miRmap web: comprehensive microRNA target prediction online,” Nucleic Acids Research, vol. 41, no. W1, pp. W165–W168, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Babapoor, R. Wu, J. Kozubek, D. Auidi, J. M. Grant-Kels, and S. S. Dadras, “Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing,” Lab Invest, vol. 97, no. 6, pp. 636–648, 2017. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Guo, W. Guo, S. Li et al., “Serum miR-16: a potential biomarker for predicting melanoma prognosis,” Journal of Investigative Dermatology, vol. 136, no. 5, pp. 985–993, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Lin, Y. Zhou, X. Lian, and Y. Tu, “Expression of microRNA-106b and its clinical significance in cutaneous melanoma,” Genetics and Molecular Research, vol. 14, no. 4, pp. 16379–16385, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Li, “Low expression of Mir-137 predicts poor prognosis in cutaneous melanoma patients,” Medical Science Monitor, vol. 22, pp. 140–144, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Dietrich and A. K. Bosserhoff, “Melanoma sponge on pigmentation gene to reduce tumour-suppressive microRNAs,” Pigment Cell & Melanoma Research, vol. 31, no. 3, pp. 350-351, 2018. View at Publisher · View at Google Scholar · View at Scopus
  46. K.-H. Kim, B.-H. Bin, J. Kim et al., “Novel inhibitory function of miR-125b in melanogenesis,” Pigment Cell & Melanoma Research, vol. 27, no. 1, pp. 140–144, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Noguchi, M. Kumazaki, Y. Yasui, T. Mori, N. Yamada, and Y. Akao, “MicroRNA-203 regulates melanosome transport and tyrosinase expression in melanoma cells by targeting kinesin superfamily protein 5b,” The Journal of Investigative Dermatology, vol. 134, no. 2, pp. 461–469, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Vitiello, A. Tuccoli, R. D'Aurizio et al., “Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells,” Oncotarget, vol. 8, no. 15, pp. 25395–25417, 2017. View at Publisher · View at Google Scholar · View at Scopus
  49. X. Dai, C. Rao, H. Li et al., “Regulation of pigmentation by microRNAs: MITF-dependent microRNA-211 targets TGF-β receptor 2,” Pigment Cell & Melanoma Research, vol. 28, no. 2, pp. 217–222, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. A. H. Shain, I. Yeh, I. Kovalyshyn et al., “The genetic evolution of melanoma from precursor lesions,” The New England Journal of Medicine, vol. 373, no. 20, pp. 1926–1936, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Xu, J. T. F. Wise, L. Wang, K. Schumann, Z. Zhang, and X. Shi, “Dual roles of oxidative stress in metal carcinogenesis,” Journal of Environmental Pathology, Toxicology and Oncology, vol. 36, no. 4, pp. 345–376, 2017. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Sangokoya, M. J. Telen, and J. T. Chi, “microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease,” Blood, vol. 116, no. 20, pp. 4338–4348, 2010. View at Publisher · View at Google Scholar · View at Scopus